ESCMID and ECMM Guidelines for the Management of Rare and Emerging Fungal Infections 2014

Total Page:16

File Type:pdf, Size:1020Kb

ESCMID and ECMM Guidelines for the Management of Rare and Emerging Fungal Infections 2014 CLINICAL MICROBIOLOGY AND INFECTION VOLUME 20, SUPPLEMENT 3, APRIL 2014 ESCMID and ECMM Guidelines for the Management of Rare and Emerging Fungal Infections GUEST EDITOR Mical Paul Publication of this supplement was commissioned and funded by ESCMID and ECMM Clinical Microbiology and Infection VOLUME 20, SUPPLEMENT 3, APRIL 2014 Editorial 1 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases O. A. Cornely, M. Cuenca-Estrella, J. F. Meis and A. J. Ullmann ESCMID and ECMM 5 ESCMID and ECMM joint clinical guidelines for the diagnosis and PUBLICATIONS management of mucormycosis 2013 O. A. Cornely, S. Arikan-Akdagli, E. Dannaoui, A. H. Groll, K. Lagrou, A. Chakrabarti, F. Lanternier, L. Pagano, A. Skiada, M. Akova, M. C. Arendrup, T. Boekhout, A. Chowdhary, M. Cuenca-Estrella, T. Freiberger, J. Guinea, J. Guarro, S. de Hoog, W. Hope, E. Johnson, S. Kathuria, M. Lackner, C. Lass-Flo¨rl, O. Lortholary, J. F. Meis, J. Meletiadis, P. Mun˜oz, M. Richardson, E. Roilides, A. M. Tortorano, A. J. Ullmann, A. van Diepeningen, P. Verweij and G. Petrikkos 27 ESCMID and ECMM joint clinical guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others A. M. Tortorano, M. Richardson, E. Roilides, A. van Diepeningen, M. Caira, P. Munoz, E. Johnson, J. Meletiadis, Z.-D. Pana, M. Lackner, P. Verweij, T. Freiberger, O. A. Cornely, S. Arikan-Akdagli, E. Dannaoui, A. H. Groll, K. Lagrou, A. Chakrabarti, F. Lanternier, L. Pagano, A. Skiada, M. Akova, M. C. Arendrup, T. Boekhout, A. Chowdhary, M. Cuenca-Estrella, J. Guinea, J. Guarro, S. de Hoog, W. Hope, S. Kathuria, O. Lortholary, J. F. Meis, A. J. Ullmann, G. Petrikkos and C. Lass-Flo¨rl 47 ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A. Chowdhary, J. F. Meis, J. Guarro, G. S. de Hoog, S. Kathuria, M. C. Arendrup, S. Arikan-Akdagli, M. Akova, T. Boekhout, M. Caira, J. Guinea, A. Chakrabarti, E. Dannaoui, A. van Diepeningen, T. Freiberger, A. H. Groll, W. W. Hope, E. Johnson, M. Lackner, K. Lagrou, F. Lanternier, C. Lass-Flo¨rl, O. Lortholary, J. Meletiadis, P. Mun˜oz, L. Pagano, G. Petrikkos, M. D. Richardson, E. Roilides, A. Skiada, A. M. Tortorano, A. J. Ullmann, P. E. Verweij, O. A. Cornely and M. Cuenca-Estrella 76 ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections M. C. Arendrup, T. Boekhout, M. Akova, J. F. Meis, O. A. Cornely, O. Lortholary and on behalf of the ESCMID EFISG study group and ECMM EDITORIAL 10.1111/1469-0691.12569 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases O. A. Cornely1, M. Cuenca-Estrella2, J. F. Meis3 and A. J. Ullmann4 1) Department I of Internal Medicine, Clinical Trials Centre Cologne, University of Cologne, ZKS K€oln, Germany, Centre for Integrated Oncology CIO K€olnBonn, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), German Centre for Infection Research, Cologne, Germany, 2) Centro Nacional de Microbiologıa, Instituto de Salud Carlos III, Madrid, Spain, 3) Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital and 4) Department of Internal Medicine II, Julius-Maximilians-University, W€urzburg, Germany E-mail: [email protected] Abstract This guideline is the second in the line of three for fungal diseases by ESCMID and other societies. The guideline tried to follow the AGREE criteria for the development of clinical guidelines. This guideline serves as a European and potentially world-wide recommendation for the diagnosis and management of rare and emerging fungi. They include mucormycosis, hyalohyphomycosis (Fusarium, Paecilomyces, Scedosporium, etc.), phaeohyphomycosis (Alternaria, Bipolaris, Cladosporium, Rhinocladiella, etc.), and emerging yeasts (Saccharomyces, Trichosporon, Rhodotorula, etc.). Introduction Still, the epidemiology of many of these rare and emerging infections is not well studied, but joint multinational efforts supported by the European Fungal Infection Study Group The European Society of Clinical Microbiology and Infectious (EFISG) of the ESCMID, the ECMM and the International Society Diseases (ESCMID) and European Confederation of Medical for Human and Animal Mycology (ISHAM) are underway [2–5]. Mycology (ECMM) wanted to tackle a challenge that no major Delayed diagnosis of IFD is a well-described problem scientific society had tried: providing a guideline on the associated with increasing mortality [5–9]. For this reason, we diagnosis and management of rare and emerging fungal aim to guide physicians on the clinical characteristics, diagnos- diseases. This guideline would obviously exclude Candida and tic utilities and appropriate treatment choice in an area of Aspergillus diseases. Practically all invasive fungal diseases (IFD), many unmet medical needs, where almost no well-designed including invasive candidiasis and aspergillosis, appear to be randomized clinical trials have been conducted. In addition, rare and emerging infections by definition. Although many IFD new diagnostic utilities are being implemented and together are still numerically rare, physicians treating immunosup- with the growth of the antifungal armamentarium, guidelines pressed patients are increasingly confronted with a wide for the correct utilization in the clinical setting are urgently variety of fungal pathogens. Rarity of disease is defined by their needed. The implementation of a pan-European guideline may absolute frequency in a population, and definitions range help national societies to strengthen their local guidelines in around 1 in 2000. Of course these statistics are different for patient care of invasive fungal diseases. populations of severely ill patients, where frequencies of IFD are much higher. Methods In the context of the numerically increasing patient population with immunosuppression and the expanding use of antifungal agents against common pathogens such as Candida Organizational structure: This guideline follows the structure and Aspergillus, the number of patients with IFD due to and definitions of the ESCMID Guideline on Candida diseases emerging and often drug-resistant pathogens is rising [1]. [7,10–14]. It is in accordance with the GRADE and AGREE ª2014 The Authors Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases 2 Clinical Microbiology and Infection, Volume 20 Supplement 3, April 2014 CMI systems with minor exceptions [15,16]. To adequately address TABLE 2. Definition of the Quality of Evidence the diversity of human fungal pathogens and to facilitate using ESCMID-EFISG and ECMM the guideline we divided the recommendations into four Level groups: (i) Mucormycosis, Cornely et al., (ii) Hyalohypho- I Evidence from at least one properly designed randomized, controlled trial € II Evidence from at least one well-designed clinical trial, without mycosis (Fusarium, Paecilomyces, Scedosporium) Lass-Florl et al., randomization; from cohort or case–control analytic studies (preferably from more than one centre); from multiple time series; or from dramatic (iii) Phaeohyphomycosis (Alternaria, Bipolaris, Cladosporium, results of uncontrolled experiments Rhinocladiella) Chowdhary et al., and (iv) emerging yeasts III Evidence from opinions of respected authorities, based on clinical experience, descriptive case studies, or reports of expert committees (Saccharomyces, Trichosporon, Rhodotorula), Arendrup et al. Index r Meta-analysis or systematic review of randomized controlled trials Members of EFISG-ESCMID and/or ECMM representing 12 t Transferred evidence, i.e. results from different patient cohorts, or similar immune-status situation European countries were invited to develop the guideline as h Comparator group is a historical control u Uncontrolled trial experts. Emerging fungal diseases differ in their regional a Abstract published at an international meeting distribution patterns even more than candidiasis and aspergil- losis, so we strengthened the group expertise by inviting non-European mycologists as well. Time schedule: In January 2012 experts were contacted by 2. Stakeholder involvement: the conveners (OAC, JM), and the chairs of the four subgroups Due to the nature of the guideline meaning that the incidence agreed to coordinate efforts. Meetings were held mostly as rates are low and diversity of patient groups is wide, patients’ telephone conferences with face-to-face meetings during ECC- views could not be sought. But the end-users were clearly MID in London in April 2012, ISHAM in Berlin in June 2012, and defined by these guidelines. stand-alone conferences in Cologne in October 2012 and These guidelines are made in collaboration between ECMM Copenhagen in November 2012, and finally recommendations and ESCMID. were presented at ECCMID in Berlin in April 2013. 3. Rigour of development: The steps of development are similar Practical Working Procedure: We followed a seven-step to those used for the previous guideline of our group [14]: approach tabulating published literature and expert opinion on a. Defining the
Recommended publications
  • Identification, Genotyping, and Pathogenicity of Trichosporon Spp
    bioRxiv preprint doi: https://doi.org/10.1101/386581; this version posted August 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Identification, Genotyping, and Pathogenicity of Trichosporon spp. Isolated from 2 Giant Pandas 3 Xiaoping Ma1#, Yaozhang Jiang1#, Chengdong Wang2*,Yu Gu3*, Sanjie Cao1, Xiaobo 4 Huang1, Yiping Wen1, Qin Zhao1,Rui Wu1, Xintian Wen1, Qigui Yan1, Xinfeng Han1, 5 Zhicai Zuo1, Junliang Deng1, Zhihua Ren1, Shumin Yu1, Liuhong Shen1, Zhijun 6 Zhong1, Guangneng Peng1, Haifeng Liu1 , Ziyao Zhou1 7 1Key Laboratory of Animal Disease and Human Health of Sichuan Province , College 8 of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China; 9 2 China Conservation and Research Center for the Giant Panda, Ya'an, Sichuan 625000, 10 China. 11 3 College of Life Sciences, Sichuan Agricultural University, Chengdu, 611130, China. 12 *Co-corresponding authors: 13 ChengdongWang: [email protected] 14 Yu Gu: [email protected]; 15 #These authors contributed equally to this work and are co-first authors. 16 The methods were carried out in accordance with the approved guidelines. 17 All animal experiments were approved by the Sichuan Agricultural University animal 18 ethics committee. 19 1 bioRxiv preprint doi: https://doi.org/10.1101/386581; this version posted August 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Monograph on Dematiaceous Fungi
    Monograph On Dematiaceous fungi A guide for description of dematiaceous fungi fungi of medical importance, diseases caused by them, diagnosis and treatment By Mohamed Refai and Heidy Abo El-Yazid Department of Microbiology, Faculty of Veterinary Medicine, Cairo University 2014 1 Preface The first time I saw cultures of dematiaceous fungi was in the laboratory of Prof. Seeliger in Bonn, 1962, when I attended a practical course on moulds for one week. Then I handled myself several cultures of black fungi, as contaminants in Mycology Laboratory of Prof. Rieth, 1963-1964, in Hamburg. When I visited Prof. DE Varies in Baarn, 1963. I was fascinated by the tremendous number of moulds in the Centraalbureau voor Schimmelcultures, Baarn, Netherlands. On the other hand, I was proud, that El-Sheikh Mahgoub, a Colleague from Sundan, wrote an internationally well-known book on mycetoma. I have never seen cases of dematiaceous fungal infections in Egypt, therefore, I was very happy, when I saw the collection of mycetoma cases reported in Egypt by the eminent Egyptian Mycologist, Prof. Dr Mohamed Taha, Zagazig University. To all these prominent mycologists I dedicate this monograph. Prof. Dr. Mohamed Refai, 1.5.2014 Heinz Seeliger Heinz Rieth Gerard de Vries, El-Sheikh Mahgoub Mohamed Taha 2 Contents 1. Introduction 4 2. 30. The genus Rhinocladiella 83 2. Description of dematiaceous 6 2. 31. The genus Scedosporium 86 fungi 2. 1. The genus Alternaria 6 2. 32. The genus Scytalidium 89 2.2. The genus Aurobasidium 11 2.33. The genus Stachybotrys 91 2.3. The genus Bipolaris 16 2.
    [Show full text]
  • Fungal Allergy and Pathogenicity 20130415 112934.Pdf
    Fungal Allergy and Pathogenicity Chemical Immunology Vol. 81 Series Editors Luciano Adorini, Milan Ken-ichi Arai, Tokyo Claudia Berek, Berlin Anne-Marie Schmitt-Verhulst, Marseille Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Fungal Allergy and Pathogenicity Volume Editors Michael Breitenbach, Salzburg Reto Crameri, Davos Samuel B. Lehrer, New Orleans, La. 48 figures, 11 in color and 22 tables, 2002 Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Chemical Immunology Formerly published as ‘Progress in Allergy’ (Founded 1939) Edited by Paul Kallos 1939–1988, Byron H. Waksman 1962–2002 Michael Breitenbach Professor, Department of Genetics and General Biology, University of Salzburg, Salzburg Reto Crameri Professor, Swiss Institute of Allergy and Asthma Research (SIAF), Davos Samuel B. Lehrer Professor, Clinical Immunology and Allergy, Tulane University School of Medicine, New Orleans, LA Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and Index Medicus. Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopy- ing, or by any information storage and retrieval system, without permission in writing from the publisher.
    [Show full text]
  • Glimpses of Antimicrobial Activity of Fungi from World
    Journal on New Biological Reports 2(2): 142-162 (2013) ISSN 2319 – 1104 (Online) Glimpses of antimicrobial activity of fungi from World Kiran R. Ranadive 1* Mugdha H. Belsare 2, Subhash S. Deokule 2, Neeta V. Jagtap 1, Harshada K. Jadhav 1 and Jitendra G. Vaidya 2 1Waghire College, Saswad, Pune – 411 055, Maharashtra, India 2Department of Botany, University of Pune, Pune (Received on: 17 April, 2013; accepted on: 12 June, 2013) ABSTRACT As we all know that certain mushrooms and several other fungi show some novel properties including antimicrobial properties against bacteria, fungi and protozoan’s. These properties play very important role in the defense against several severe diseases caused by bacteria, fungi and other organisms also. In the available recent literature survey, many interesting observations have been made regarding antimicrobial activity of fungi. In particular this study shows total 316 species of 150 genera from 64 Fungal families (45 Basidiomycetous and 21 Ascomycetous families {6 Lichenized, 15 Non-Lichenized and 3 Incertae sedis)} are reported so far from world showing antibacterial activity against 32 species of 18 genera of bacteria and 22 species of 13 genera of fungi. This data materialistically adds the hidden potential of these reported fungi and it also clears the further line of action for the study of unknown medicinal fungi useful in human life. Key Words: Fungi, antimicrobial activity, microbes INTRODUCTION Fungi and animals are more closely related to one In recent in vitro study, extracts of more than 75 another than either is to plants, diverging from plants percent of polypore mushroom species surveyed more than 460 million years ago (Redecker 2000).
    [Show full text]
  • Identification, Genotyping, and Pathogenicity of Trichosporon Spp
    bioRxiv preprint doi: https://doi.org/10.1101/386581; this version posted August 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Identification, Genotyping, and Pathogenicity of Trichosporon spp. Isolated from 2 Giant Pandas 3 Xiaoping Ma1#, Yaozhang Jiang1#, Chengdong Wang2*,Yu Gu3*, Sanjie Cao1, Xiaobo 4 Huang1, Yiping Wen1, Qin Zhao1,Rui Wu1, Xintian Wen1, Qigui Yan1, Xinfeng Han1, 5 Zhicai Zuo1, Junliang Deng1, Zhihua Ren1, Shumin Yu1, Liuhong Shen1, Zhijun 6 Zhong1, Guangneng Peng1, Haifeng Liu1 , Ziyao Zhou1 7 1Key Laboratory of Animal Disease and Human Health of Sichuan Province , College 8 of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China; 9 2 China Conservation and Research Center for the Giant Panda, Ya'an, Sichuan 625000, 10 China. 11 3 College of Life Sciences, Sichuan Agricultural University, Chengdu, 611130, China. 12 *Co-corresponding authors: 13 ChengdongWang: [email protected] 14 Yu Gu: [email protected]; 15 #These authors contributed equally to this work and are co-first authors. 16 The methods were carried out in accordance with the approved guidelines. 17 All animal experiments were approved by the Sichuan Agricultural University animal 18 ethics committee. 19 1 bioRxiv preprint doi: https://doi.org/10.1101/386581; this version posted August 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Towards an Integrated Phylogenetic Classification of the Tremellomycetes
    http://www.diva-portal.org This is the published version of a paper published in Studies in mycology. Citation for the original published paper (version of record): Liu, X., Wang, Q., Göker, M., Groenewald, M., Kachalkin, A. et al. (2016) Towards an integrated phylogenetic classification of the Tremellomycetes. Studies in mycology, 81: 85 http://dx.doi.org/10.1016/j.simyco.2015.12.001 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:nrm:diva-1703 available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 81: 85–147. Towards an integrated phylogenetic classification of the Tremellomycetes X.-Z. Liu1,2, Q.-M. Wang1,2, M. Göker3, M. Groenewald2, A.V. Kachalkin4, H.T. Lumbsch5, A.M. Millanes6, M. Wedin7, A.M. Yurkov3, T. Boekhout1,2,8*, and F.-Y. Bai1,2* 1State Key Laboratory for Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, PR China; 2CBS Fungal Biodiversity Centre (CBS-KNAW), Uppsalalaan 8, Utrecht, The Netherlands; 3Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig 38124, Germany; 4Faculty of Soil Science, Lomonosov Moscow State University, Moscow 119991, Russia; 5Science & Education, The Field Museum, 1400 S. Lake Shore Drive, Chicago, IL 60605, USA; 6Departamento de Biología y Geología, Física y Química Inorganica, Universidad Rey Juan Carlos, E-28933 Mostoles, Spain; 7Department of Botany, Swedish Museum of Natural History, P.O. Box 50007, SE-10405 Stockholm, Sweden; 8Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, PR China *Correspondence: F.-Y.
    [Show full text]
  • Carrol, F. E. Y Carrol, G. C. 1973. Senescence and Death of Conidiogenous Cell in Stemphylium
    UNIVERSITAT ROVIRA I VIRGILI ESTUDIO TAXONOMICO DE LOS ASCOMYCETES DEL SUELO Akberto Miguel Stchingel Glikman ISBN:978-84-691-1881-8 /DL: T-342-2008 .- Carrol, F. E. y Carrol, G. C. 1973. Senescence and death of conidiogenous cell in Stemphylium botryosum Wallroth, Archives of Microbiology 94, 109-124. .- Carroll, G. C. y Wicklow, D. T. 1992. The fungal community: Its organization, and role in the ecosystem. Marcel Dekker Inc., New York. .- Cavalier-Smith, T. 1987. The origin of the fungi and the pseudofungi. En: Rayner, A. D. M., Brasier, C. M. y Moore, D. (eds.) Evolutionary biology of the fungi, pp. 339-353. Cambridge University Press, Cambridge. .- Cochrane, V. W. 1958. Fisiology of the fungi. John Wiley, New York. .- Cochrane, V. W. 1960. Spore germination. En: Horsfall, J. y Diamond, A. (eds.) Plant pathology: an advanced treatise, vol. 2, pp. 167-202. Academic Press, New York-London. .- Cooke, R. C. y Whipps, J. M. 1993. Ecophysiology of Fungi. Blackwell Scientific Publications, Oxford. .- Currah, R. S. 1985. Taxonomy of the Onygenales: Arthrodermataceae, Gymnoascaceae, Myxotrichaceae and Onygenaceae. Mycotaxon 24,1-2Í6. .- Chesters, C. G. C. 1949. Concerning fungi inhabiting soil. Transactions of the British Mycological Society 32, 197-216. 185 L UNIVERSITAT ROVIRA I VIRGILI ESTUDIO TAXONOMICO DE LOS ASCOMYCETES DEL SUELO Akberto Miguel Stchingel Glikman ISBN:978-84-691-1881-8 /DL: T-342-2008 .- Chinn, S. H. F. y Ledingham, R. J. 1957. Studies on the influence of various substances on the germination of Helminthosporium sativum. Canadian Journal of Botany 35, 679-701. .- Dix, N. J. y Webster, J.
    [Show full text]
  • Morphological and Biochemical Characterization of the Aetiological Agents of White Piedra
    786 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 103(8): 786-790, December 2008 Morphological and biochemical characterization of the aetiological agents of white piedra Alba Regina Magalhães1/+, Silvia Susana Bona de Mondino1, Manuela da Silva2, Marilia Martins Nishikawa3 Laboratório de Micologia, Instituto Biomédico 1Programa de Pós-Graduação em Patologia, Departamento de Patologia, Universidade Federal Fluminense, Rua Marquês de Paraná 303, 24030-210, Niterói, RJ, Brasil 2Programa de Pós-Graduação em Vigilância Sanitária 3Setor de Fungos de Referência, Departamento de Microbiologia, Instituto Nacional de Controle de Qualidade-Fiocruz, Rio de Janeiro, RJ, Brasil The Trichosporon genus is constituted by many species, of which Trichosporon ovoides and Trichosporon inkin are the causative agents of white piedra. They can cause nodules in genital hair or on the scalp. At present, Brazilian laboratory routines generally do not include the identification of the species of Trichosporon genus, which, although morphologically and physiologically distinct, present many similarities, making the identification difficult. The aim of this study was to identify the aetiological agents at the species level of white piedra from clinical specimens. Therefore, both the macro and micro morphology were studied, and physiological tests were performed. Tricho- sporon spp. was isolated from 10 clinical samples; T. ovoides was predominant, as it was found in seven samples, while T. inkin was identified just in two samples. One isolate could not be identified at the species level. T. inkin was identified for the first time as a white piedra agent in the hair shaft on child under the age of 10. Key words: Trichosporon - white piedra - mycosis - phenotypic identification Trichosporon Behrend is a genus that belongs to White piedra, a mycosis that occurs in some animals, the Basidiomycota phylum, the Hymenomycetes class such as horses, monkeys and domestic animals, as well and the Trichosporonales order (Fell et al.
    [Show full text]
  • 12 Tremellomycetes and Related Groups
    12 Tremellomycetes and Related Groups 1 1 2 1 MICHAEL WEIß ,ROBERT BAUER ,JOSE´ PAULO SAMPAIO ,FRANZ OBERWINKLER CONTENTS I. Introduction I. Introduction ................................ 00 A. Historical Concepts. ................. 00 Tremellomycetes is a fungal group full of con- B. Modern View . ........................... 00 II. Morphology and Anatomy ................. 00 trasts. It includes jelly fungi with conspicuous A. Basidiocarps . ........................... 00 macroscopic basidiomes, such as some species B. Micromorphology . ................. 00 of Tremella, as well as macroscopically invisible C. Ultrastructure. ........................... 00 inhabitants of other fungal fruiting bodies and III. Life Cycles................................... 00 a plethora of species known so far only as A. Dimorphism . ........................... 00 B. Deviance from Dimorphism . ....... 00 asexual yeasts. Tremellomycetes may be benefi- IV. Ecology ...................................... 00 cial to humans, as exemplified by the produc- A. Mycoparasitism. ................. 00 tion of edible Tremella fruiting bodies whose B. Tremellomycetous Yeasts . ....... 00 production increased in China alone from 100 C. Animal and Human Pathogens . ....... 00 MT in 1998 to more than 250,000 MT in 2007 V. Biotechnological Applications ............. 00 VI. Phylogenetic Relationships ................ 00 (Chang and Wasser 2012), or extremely harm- VII. Taxonomy................................... 00 ful, such as the systemic human pathogen Cryp- A. Taxonomy in Flow
    [Show full text]
  • A Worldwide List of Endophytic Fungi with Notes on Ecology and Diversity
    Mycosphere 10(1): 798–1079 (2019) www.mycosphere.org ISSN 2077 7019 Article Doi 10.5943/mycosphere/10/1/19 A worldwide list of endophytic fungi with notes on ecology and diversity Rashmi M, Kushveer JS and Sarma VV* Fungal Biotechnology Lab, Department of Biotechnology, School of Life Sciences, Pondicherry University, Kalapet, Pondicherry 605014, Puducherry, India Rashmi M, Kushveer JS, Sarma VV 2019 – A worldwide list of endophytic fungi with notes on ecology and diversity. Mycosphere 10(1), 798–1079, Doi 10.5943/mycosphere/10/1/19 Abstract Endophytic fungi are symptomless internal inhabits of plant tissues. They are implicated in the production of antibiotic and other compounds of therapeutic importance. Ecologically they provide several benefits to plants, including protection from plant pathogens. There have been numerous studies on the biodiversity and ecology of endophytic fungi. Some taxa dominate and occur frequently when compared to others due to adaptations or capabilities to produce different primary and secondary metabolites. It is therefore of interest to examine different fungal species and major taxonomic groups to which these fungi belong for bioactive compound production. In the present paper a list of endophytes based on the available literature is reported. More than 800 genera have been reported worldwide. Dominant genera are Alternaria, Aspergillus, Colletotrichum, Fusarium, Penicillium, and Phoma. Most endophyte studies have been on angiosperms followed by gymnosperms. Among the different substrates, leaf endophytes have been studied and analyzed in more detail when compared to other parts. Most investigations are from Asian countries such as China, India, European countries such as Germany, Spain and the UK in addition to major contributions from Brazil and the USA.
    [Show full text]
  • Redalyc.Genotype, Antifungal Susceptibility, and Biofilm Formation of Trichosporon Asahii Isolated from the Urine of Hospitalize
    Revista Argentina de Microbiología ISSN: 0325-7541 [email protected] Asociación Argentina de Microbiología Argentina Araújo de Almeida, Adriana; do Amaral Crispim, Bruno; Barufatti Grisolia, Alexéia; Estivalet Svidzinski, Terezinha Inez; Gonçalvez Ortolani, Lais; Pires de Oliveira, Kelly Mari Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients Revista Argentina de Microbiología, vol. 48, núm. 1, 2016, pp. 62-66 Asociación Argentina de Microbiología Buenos Aires, Argentina Available in: http://www.redalyc.org/articulo.oa?id=213045299010 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Rev Argent Microbiol. 2016;48(1):62---66 R E V I S T A A R G E N T I N A D E MICROBIOLOGÍA www.elsevier.es/ram BRIEF REPORT Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients a b Adriana Araújo de Almeida , Bruno do Amaral Crispim , c d Alexéia Barufatti Grisolia , Terezinha Inez Estivalet Svidzinski , a a,∗ Lais Gonc¸alvez Ortolani , Kelly Mari Pires de Oliveira a Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil b Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados, Mato Grosso do
    [Show full text]
  • Supplement Hoenigl TLID 2021 Global Guideline for the Diagnosis
    Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hoenigl M, Salmanton-García J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis 2021; published online Feb 16. https://doi.org/10.1016/S1473-3099(20)30784-2. 1 Global guideline for the diagnosis and management of rare 2 mold infections: An initiative of the ECMM in cooperation 3 with ISHAM and ASM* 4 5 Authors 6 Martin Hoenigl (FECMM)1,2,3,54,55#, Jon Salmanton-García4,5,30,55, Thomas J. Walsh (FECMM)6, Marcio 7 Nucci (FECMM)7, Chin Fen Neoh (FECMM)8,9, Jeffrey D. Jenks2,3,10, Michaela Lackner (FECMM)11,55, Ro- 8 sanne Sprute4,5,55, Abdullah MS Al-Hatmi (FECMM)12, Matteo Bassetti13, Fabianne Carlesse 9 (FECMM)14,15, Tomas Freiberger16, Philipp Koehler (FECMM)4,5,17,30,55, Thomas Lehrnbecher18, Anil Ku- 10 mar (FECMM)19, Juergen Prattes (FECMM)1,55, Malcolm Richardson (FECMM)20,21,55,, Sanjay Revankar 11 (FECMM)22, Monica A. Slavin23,24, Jannik Stemler4,5,55, Birgit Spiess25, Saad J. Taj-Aldeen26, Adilia Warris 12 (FECMM)27, Patrick C.Y. Woo (FECMM)28, Jo-Anne H. Young29, Kerstin Albus4,30,55, Dorothee Arenz4,30,55, 13 Valentina Arsic-Arsenijevic (FECMM)31,54, Jean-Philippe Bouchara32,33, Terrence Rohan Chinniah34, Anu- 14 radha Chowdhary (FECMM)35, G Sybren de Hoog (FECMM)36, George Dimopoulos (FECMM)37, Rafael F.
    [Show full text]